We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Prescription medication — not a dietary supplement
Lithium (low-dose)is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Most Lithium (low-dose) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality studies published 2011–2026.
Based on 6 studies
Confidence
LowBy outcome
Lithium (low-dose) has an evidence score of 3/10 — emerging evidence based on 6 indexed studies. An element and mood-stabilizer drug studied at low doses as a geroprotector and neuroprotectant. Intriguing signals — drinking-water epidemiology links trace lithium to lower mortality and dementia, and it extends lifespan in worms — but human evidence is associational, model-organism results are mixed, and therapeutic lithium has a narrow safety window. A prescription drug used off-label; the OTC microdose form is lithium orotate. Representative study: PMID 39212809.
The commonly studied dose of Lithium (low-dose) is Geroprotective interest centers on LOW doses far below bipolar dosing. The OTC microdose form is lithium orotate (~1–5 mg elemental lithium; see that supplement). Therapeutic lithium carbonate (hundreds of mg, blood-level-monitored) is a different, higher-risk regimen used for bipolar disorder under a clinician. No validated longevity dose exists.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Lithium (low-dose / pharmacological)
An element and mood-stabilizer drug studied at low doses as a geroprotector and neuroprotectant. Intriguing signals — drinking-water epidemiology links trace lithium to lower mortality and dementia, and it extends lifespan in worms — but human evidence is associational, model-organism results are mixed, and therapeutic lithium has a narrow safety window. A prescription drug used off-label; the OTC microdose form is lithium orotate.
Low-dose lithium has a robust neuroprotective mechanism (GSK-3 inhibition, autophagy, BDNF) and suggestive drinking-water epidemiology linking it to lower mortality and dementia, but the human evidence is associational, model-organism lifespan results are mixed/sex-dependent, and therapeutic lithium has a narrow safety window — so the geroprotector case is intriguing but unproven.
Lithium is a trace element and the long-standing gold-standard drug for bipolar disorder (as lithium carbonate). Its geroscience interest comes from several converging but soft lines of evidence.
Mechanistically, lithium inhibits glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase, enhances autophagy, boosts neurotrophic signaling (BDNF), and is broadly neuroprotective across cell, tissue, and animal models — pathways highly relevant to brain aging and neurodegeneration.
Epidemiologically, the influential Zarse 2011 analysis found that regions with higher trace lithium in drinking water had lower all-cause mortality, and that low-dose lithium extended lifespan in the worm C. elegans; subsequent population studies have repeatedly (though not uniformly) linked higher drinking-water lithium to lower dementia incidence.
Small human trials of low-dose lithium in mild cognitive impairment and Alzheimer's disease suggest cognitive stabilization and biomarker effects, and a recent pilot randomized trial in MCI examined its feasibility, safety, and preliminary efficacy.
The honest picture is that none of this is proof of human longevity: the drinking-water data are observational and confounded, the model-organism lifespan results are mixed (lithium's effect in Drosophila is dose- and sex-dependent and can reduce the female lifespan advantage), and the human cognitive trials are small and preliminary.
Safety is the other key caveat: at therapeutic (bipolar) doses lithium has a narrow window with real toxicity — thyroid suppression, kidney effects, tremor, and dangerous toxicity in overdose or dehydration — so longevity interest centers on much lower 'microdoses,' which are far safer but also far less proven.
The OTC microdose form sold as a supplement is lithium orotate (covered separately); this entry covers pharmacological/low-dose lithium used off-label for neuroprotection/longevity.
The score reflects a strong neuroprotective mechanism and suggestive epidemiology against associational-only human data, mixed animal results, and a narrow therapeutic-dose safety window.
Lithium inhibits glycogen synthase kinase-3, a kinase central to tau phosphorylation, circadian and metabolic signaling — a key proposed neuroprotective/anti-aging mechanism.
By inhibiting inositol monophosphatase and lowering inositol, lithium induces autophagy, clearing aggregated proteins implicated in neurodegeneration.
Lithium raises BDNF and pro-survival signaling and is neuroprotective across many models — the basis of its dementia and longevity interest.
How Lithium (low-dose) works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
Geroprotective interest centers on LOW doses far below bipolar dosing. The OTC microdose form is lithium orotate (~1–5 mg elemental lithium; see that supplement). Therapeutic lithium carbonate (hundreds of mg, blood-level-monitored) is a different, higher-risk regimen used for bipolar disorder under a clinician. No validated longevity dose exists.
Take with food
| Form | Type |
|---|---|
| 💊Low-dose / lithium orotate (microdose) | Recommended |
| 💊Lithium carbonate (prescription, bipolar) | Alternative |
The supplement microdose form is lithium orotate; therapeutic lithium carbonate is a monitored prescription drug.
Minimum: 12 weeks
Optimal: 52 weeks
Cycling: Not required
Note: With food and adequate hydration; therapeutic doses need blood-level monitoring. Longevity interest is in microdoses.
Dose-response data unavailable. The current published research for Lithium (low-dose) does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Higher trace lithium in drinking water is associated with lower all-cause mortality — observational, not causal.
Population studies repeatedly (not uniformly) link higher drinking-water lithium to lower dementia incidence; small MCI/AD trials suggest cognitive stabilization.
Extends lifespan in C. elegans; in Drosophila the effect is dose- and sex-dependent and can reduce the female lifespan advantage — not shown in mammals/humans.
Therapeutic lithium can suppress thyroid, affect the kidneys, cause tremor, and is dangerous in overdose/dehydration; microdoses are far safer but less proven.
Therapeutic lithium carries a cardiac-malformation risk; use only under specialist guidance.
High toxicity risk — avoid or monitor closely at therapeutic doses.
Much lower risk, but evidence is weaker; see the lithium-orotate entry.
Reduce lithium clearance and can raise levels into the toxic range — a classic, dangerous interaction at therapeutic doses.
Raise lithium concentration and toxicity risk.
Tip: Dose-related; far less likely at microdoses.
Tip: Monitor thyroid on longer/therapeutic use.
Tip: Therapeutic dosing requires blood-level and renal monitoring; toxicity is a medical emergency.
Timing is flexible for Lithium (low-dose) — consistent daily use matters more than the time of day. Take with food/water to limit GI upset; stay hydrated (dehydration raises lithium levels).
Lithium (low-dose) should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are tremor / GI upset, thyroid suppression (hypothyroidism), kidney effects / lithium toxicity. Use caution if any of these apply to you: Significant renal impairment; Dehydration / significant sodium depletion; Pregnancy (cardiac malformation risk at therapeutic doses).
A dietary flavonoid with anti-inflammatory effects in the lab. The honest verdict: the only direct human RCTs test PEA-luteolin combinations for post-COVID smell loss — isolated luteolin's anti-inflammatory, allergy, and brain claims rest on mechanism and reviews, not human trials, and its bioavailability is low.